Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Erwin R BoghaertNitin K Damle

Abstract

Linking a cytotoxic anticancer drug to an antibody that recognizes a tumor-associated antigen can improve the therapeutic index of the drug. We asked whether a conjugate of the cytotoxic antibiotic N-acetyl gamma calicheamicin dimethyl hydrazide (CalichDMH) and an antibody recognizing Lewis(y) (Le(y)) antigen could eliminate carcinomas that express Le(y). Because Le(y) is highly expressed on carcinomas of colon, breast, lung, ovary, and prostate, a CalichDMH conjugate targeting Le(y) could provide a treatment option for various cancers. The humanized anti-Le(y) antibody hu3S193 was conjugated to CalichDMH via the bifunctional AcBut linker. Selectivity and avidity of the conjugate (hu3S193-CalichDMH) for Le(y)-BSA or Le(y+) cells was tested by BIAcore or flow cytometry. Cytotoxicity of hu3S193-CalichDMH was compared with toxicity of a control conjugate on monolayers of Le(y+) and Le(y-) carcinoma cells. Inhibition of tumor growth by hu3S193-CalichDMH was assessed on three types of s.c. xenografts. Hu3S193-CalichDMH had similar selectivity as hu3S193. The conjugate had lower affinity for Le(y)-BSA but not for Le(y+) cells. When tested on monolayers of human Le(y+) carcinoma cells, hu3S193-CalichDMH was more cytotoxic than a contr...Continue Reading

References

Apr 1, 1990·Pharmaceutical Research·Y TakakuraH Sezaki
Feb 1, 1991·Current Opinion in Oncology·D K Kalwinsky
Jun 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M M MareelE R Boghaert
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·K KitamuraL J Old
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·C LiuR V Chari
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·S ZhangP O Livingston
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A W TolcherW Slichenmyer
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman

❮ Previous
Next ❯

Citations

Apr 9, 2013·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Slavica StojnevTakanori Hattori
Jul 20, 2011·ACS Chemical Biology·Yuelong MaAndrew M Scott
Mar 16, 2011·Chemical Reviews·Jonas J Forsman, Reko Leino
Sep 10, 2005·Nature Biotechnology·Anna M Wu, Peter D Senter
Jun 10, 2008·The Cancer Journal·Paul J Carter, Peter D Senter
Mar 11, 2005·Expert Review of Anticancer Therapy·Christopher F Nicodemus, Jonathan S Berek
Sep 1, 2015·Journal of Industrial Microbiology & Biotechnology·Jeffrey D RudolfBen Shen
Sep 1, 2004·Expert Opinion on Biological Therapy·Nitin K Damle
Oct 3, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lee M KrugChaitanya Divgi
Apr 9, 2011·New Biotechnology·Vinochani PillayAndrew M Scott
Jan 18, 2011·Advanced Drug Delivery Reviews·L BildsteinP Couvreur
Sep 16, 2014·Bioconjugate Chemistry·Tyson SmythThomas J Anchordoquy
May 6, 2009·Current Opinion in Chemical Biology·Peter D Senter
Oct 28, 2005·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Jan 15, 2009·Scandinavian Journal of Immunology·P A ChristensenS Goletz
Apr 29, 2015·Chemical Reviews·Pamela T Wong, Seok Ki Choi
Feb 13, 2013·Carbohydrate Polymers·A T LewisP D Lewis
Dec 2, 2010·Natural Product Reports·Barbara La FerlaFrancesco Nicotra
Dec 17, 2004·Nature·Jon Clardy, Christopher Walsh
Mar 26, 2010·Natural Product Reports·Zhao-Xun Liang
Jun 21, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael P Hall
Dec 5, 2019·The American Journal of Chinese Medicine·Han XiaoJunling Yang
Oct 22, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Umbreen HafeezAndrew M Scott
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marcus P KellyAndrew M Scott
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew M ScottLloyd J Old
Mar 19, 2021·Chemical Society Reviews·Yufei XueNicolas Hans Voelcker
Feb 11, 2005·Chemical Reviews·Ute GalmBen Shen
Mar 17, 2021·Molecular Cancer Therapeutics·Breanna S VollmarThomas H Pillow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.